Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.6301
+0.0101 (1.63%)
At close: Jun 5, 2025, 4:00 PM
0.6103
-0.0198 (-3.14%)
After-hours: Jun 5, 2025, 5:23 PM EDT

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4769119123359379
Upgrade
Market Cap Growth
-38.74%-42.03%-2.89%-65.85%-5.17%3.77%
Upgrade
Enterprise Value
41468183295295
Upgrade
Last Close Price
0.621.092.642.8511.3112.51
Upgrade
PS Ratio
4.857.4421.7098.5324.04120.08
Upgrade
PB Ratio
5.823.953.211.875.494.80
Upgrade
P/TBV Ratio
7.213.953.211.875.494.80
Upgrade
EV/Sales Ratio
5.074.9714.7266.7519.7693.58
Upgrade
Debt / Equity Ratio
1.080.510.400.290.150.09
Upgrade
Asset Turnover
0.210.200.070.010.160.04
Upgrade
Quick Ratio
0.911.782.966.615.285.29
Upgrade
Current Ratio
1.031.843.016.685.355.37
Upgrade
Return on Equity (ROE)
-221.66%-149.03%-98.73%-80.82%-61.16%-67.10%
Upgrade
Return on Assets (ROA)
-67.62%-55.47%-42.53%-38.29%-29.87%-32.90%
Upgrade
Return on Capital (ROIC)
-90.82%-66.52%-47.52%-41.66%-33.81%-38.45%
Upgrade
Earnings Yield
-85.49%-58.90%-42.59%-43.21%-12.29%-11.82%
Upgrade
FCF Yield
-73.47%-52.71%-33.55%-34.22%-11.07%-8.74%
Upgrade
Buyback Yield / Dilution
-33.15%-23.11%-28.35%-13.95%-9.05%-30.16%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q